{
    "organizations": [],
    "uuid": "a5d35095d16b5908ac11820f7fe9b71d8beab5f4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-allergan-anticipates-q4-net-deferr/brief-allergan-anticipates-q4-net-deferred-tax-benefit-of-3-5-bln-to-4-bln-idUSFWN1P30WU",
    "ord_in_thread": 0,
    "title": "BRIEF-Allergan Anticipates Q4 Net Deferred Tax Benefit Of $3.5 Bln To $4 Bln‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 8 (Reuters) - Allergan Plc:\n* ALLERGAN - CURRENTLY ANTICIPATES RECORDING IN Q4 2017, NET DEFERRED TAX BENEFIT OF $3.5 BILLION TO $4.0 BILLION RELATED TO U.S. TAX CUT AND JOBS ACT‍​\n* ALLERGAN-‍ANTICIPATES RECORDING IN Q4 2017,TAX EXPENSE OF $700-$800 MILLION RELATED TO 'TOLL CHARGE' NET OF ESTIMATED FOREIGN TAX CREDITS RELATED TO TCJA Source text: ( bit.ly/2meqQGB ) Further company coverage:\n ",
    "published": "2018-01-09T06:19:00.000+02:00",
    "crawled": "2018-01-09T16:49:12.023+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "allergan",
        "plc",
        "allergan",
        "currently",
        "anticipates",
        "recording",
        "q4",
        "net",
        "deferred",
        "tax",
        "benefit",
        "billion",
        "billion",
        "related",
        "tax",
        "cut",
        "job",
        "recording",
        "q4",
        "tax",
        "expense",
        "million",
        "related",
        "charge",
        "net",
        "estimated",
        "foreign",
        "tax",
        "credit",
        "related",
        "tcja",
        "source",
        "text",
        "company",
        "coverage"
    ]
}